Glyconex MV 2mg/500mg/0.2mg Tablet SR
Marketer
Norlis Life Sciences Pvt Ltd
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.2mg)
Overview Glyconex MV 2mg/500mg/0.2mg Tablet SR
Diabetic patients using the extended-release Glyconex MV tablet (2mg/500mg/0.2mg) should understand its role as an anti-diabetic combination medication for managing type 2 diabetes in adults. This medication helps regulate blood glucose, and consistent daily dosing, ideally at the same time each day with food, maximizes effectiveness. Dosage adjustments are determined by your physician based on your blood sugar monitoring. Discontinuing Glyconex MV without medical supervision is risky; abrupt cessation can elevate blood sugar levels, increasing the risk of complications such as nephropathy, retinopathy, neuropathy, and peripheral vascular disease. Glyconex MV is part of a comprehensive treatment plan that must include diet, exercise, and weight management as directed by your doctor. Hypoglycemia (low blood sugar) is the most frequent adverse event. Learn to recognize its symptoms (sweating, dizziness, headache, tremors) and how to treat it; carry a readily available fast-acting glucose source (e.g., glucose tablets, fruit juice). Alcohol consumption raises your hypoglycemia risk and should be limited. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, edema, visual disturbances, fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated for patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Those with a history of cardiac disease should inform their physician before initiating treatment. Consult your doctor before using Glyconex MV if you are pregnant or breastfeeding. Regular blood glucose monitoring is essential, and your doctor may order blood tests to track your complete blood count and liver function.
Primary Ingredients of Glyconex MV 2mg/500mg/0.2mg Tablet SR
No text provided to rephrase.
Uses of Glyconex MV 2mg/500mg/0.2mg Tablet SR
Managing type 2 diabetes
Major Benefits of Glyconex MV 2mg/500mg/0.2mg Tablet SR:
Consume Glyconex MV 2mg/500mg/0.2mg SR tablets exactly as prescribed by your physician. Ingest the tablets whole; avoid chewing, crushing, or fracturing them. Administer on an empty stomach.
Common Side effects of Glyconex MV 2mg/500mg/0.2mg Tablet SR:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Glyconex MV 2mg/500mg/0.2mg Tablet SR:
Consume Glyconex MV 2mg/500mg/0.2mg Tablet SR precisely as directed by your physician, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication on an empty stomach.
How Glyconex MV 2mg/500mg/0.2mg Tablet SR works:
Extended-release Glyconex MV tablets (2mg/500mg/0.2mg) contain a triple-action antidiabetic formulation.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Glyconex MV 2mg/500mg/0.2mg SR tablets is unsafe.
PregnancyCONSULT YOUR DOCTOR
The use of Glyconex MV 2mg/500mg/0.2mg Extended-Release tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing this medication. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Glyconex MV tablet (2mg/500mg/0.2mg) is likely unsafe for breastfeeding mothers. Available evidence from human studies indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.
KidneyUNSAFE
Employing Glyconex MV 2mg/500mg/0.2mg Tablet SR carries a high likelihood of risk for individuals with kidney impairment and should be forgone. Medical advice is recommended. Furthermore, its use is contraindicated in patients exhibiting severe renal dysfunction.
LiverCAUTION
Patients with liver impairment should use Glyconex MV 2mg/500mg/0.2mg SR tablets cautiously, potentially requiring dose modification. A physician's consultation is advised. For those with mild to moderate liver disease, initiation should be at a low dose; the medication is contraindicated in patients with severe hepatic dysfunction.
What if you forget to take Glyconex MV 2mg/500mg/0.2mg Tablet SR :
Should you forget a Glyconex MV 2mg/500mg/0.2mg Tablet SR dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glyconex MV 2mg/500mg/0.2mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes medication |
3,018 People bought this recently